Rilmenidine alters renal function when administered intracerebroventricularly or intrarenally.
Penner
S B
SB
Department of Pharmacology & Therapeutics, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
Smyth
D D
DD
D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D004333:Drug Administration Routes; D054755:Imidazoline Receptors; D007668:Kidney / Q000187:drug effects* / Q000502:physiology; D010080:Oxazoles / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011955:Receptors, Drug / Q000187:drug effects; D012077:Renal Artery; D000077769:Rilmenidine
D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists; D054755:Imidazoline Receptors; D010080:Oxazoles; D011955:Receptors, Drug; D000077769:Rilmenidine